Robert LaCaze, incoming CEO of Mnemo Therapeutics

Bay­er on­col­o­gy vet Robert La­Caze has his eyes on next steps — land­ing his first gig as CEO of Sade­lain co-found­ed biotech

Three weeks af­ter Bay­er put out word that Robert La­Caze, its head of their on­col­o­gy strate­gic busi­ness unit, was jump­ing ship, we now know where …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.